Care for women with prior preterm birth.

Women who have delivered an infant between 16 and 36 weeks' gestation have an increased risk of preterm birth in subsequent pregnancies. The risk increases with more than 1 preterm birth and is inversely proportional to the gestational age of the previous preterm birth. African American women have rates of recurrent preterm birth that are nearly twice that of women of other backgrounds. An approximate risk of recurrent preterm birth can be estimated by a comprehensive reproductive history, with emphasis on maternal race, the number and gestational age of prior births, and the sequence of events preceding the index preterm birth. Interventions including smoking cessation, eradication of asymptomatic bacteriuria, progestational agents, and cervical cerclage can reduce the risk of recurrent preterm birth when employed appropriately.

[1]  L. Poston,et al.  Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial , 2006, The Lancet.

[2]  G. Thurnau,et al.  Are women with recurrent spontaneous preterm births different from those without such history? , 2006, American journal of obstetrics and gynecology.

[3]  J. Martin,et al.  Births: preliminary data for 2005. , 2006, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[4]  H. Wilson,et al.  Rates of and factors associated with recurrence of preterm delivery. , 2000, JAMA.

[5]  L. Dodds,et al.  Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. , 2003, American journal of obstetrics and gynecology.

[6]  B. Sibai,et al.  Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery. , 2004, American journal of obstetrics and gynecology.

[7]  M. Kaminski,et al.  History of induced abortion as a risk factor for preterm birth in European countries: results of the EUROPOP survey. , 2004, Human reproduction.

[8]  P. Shah,et al.  Knowledge Synthesis Group of Determinants of preterm/LBW births. Induced termination of pregnancy and low birthweight and preterm birth: a systematic review and meta-analyses , 2009 .

[9]  H. V. van Geijn,et al.  Cervical incompetence prevention randomized cerclage trial (CIPRACT): study design and preliminary results. , 2000, American journal of obstetrics and gynecology.

[10]  Dennis A. Mitchell,et al.  Treatment of periodontal disease and the risk of preterm birth. , 2006, The New England journal of medicine.

[11]  B. Mercer,et al.  Periviable birth at 20 to 26 weeks of gestation: proximate causes, previous obstetric history and recurrence risk. , 2005, American journal of obstetrics and gynecology.

[12]  F. Facchinetti,et al.  Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. , 2007, American journal of obstetrics and gynecology.

[13]  Vincenzo Berghella,et al.  Preterm birth : prevention and management , 2010 .

[14]  R. Newman,et al.  Interobserver reliability of digital and endovaginal ultrasonographic cervical length measurements. , 1997, American journal of obstetrics and gynecology.

[15]  S F Bottoms,et al.  The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. , 1998, American journal of public health.

[16]  E. Thom,et al.  The Preterm Prediction Study: Fetal Fibronectin, Bacterial Vaginosis, and Peripartum Infection , 1996, Obstetrics and gynecology.

[17]  J. Thorp,et al.  Prevention of Preterm Birth in Triplets Using 17 Alpha-Hydroxyprogesterone Caproate: A Randomized Controlled Trial , 2009, Obstetrics and gynecology.

[18]  B. V. Voorhis Outcomes from assisted reproductive technology. , 2006 .

[19]  The therapeutic value of maintenance tocolysis: an overview of the evidence. , 2003, Clinics in perinatology.

[20]  R. Kakuma,et al.  Energy and protein intake in pregnancy. , 2003, The Cochrane database of systematic reviews.

[21]  H. Baker,et al.  Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection. , 2008, Human reproduction.

[22]  R. Romero,et al.  Ultrasonographic examination of the uterine cervix is better than cervical digital examination as a predictor of the likelihood of premature delivery in patients with preterm labor and intact membranes. , 1994, American journal of obstetrics and gynecology.

[23]  T. Garite,et al.  Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. , 2009, American journal of obstetrics and gynecology.

[24]  R. Newman,et al.  South Carolina Partners for Preterm Birth Prevention: a regional perinatal initiative for the reduction of premature birth in a Medicaid population. , 2007, American journal of obstetrics and gynecology.

[25]  Elizabeth A Thom,et al.  A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. , 2007, The New England journal of medicine.

[26]  M. Zugaib,et al.  Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. , 2003, American journal of obstetrics and gynecology.

[27]  M. Klebanoff,et al.  Treatment of Vaginal Infections to Prevent Preterm Birth: A Meta-Analysis , 2004, Clinical obstetrics and gynecology.

[28]  J. Crane,et al.  Use of transvaginal ultrasonography to predict preterm birth in women with a history of preterm birth , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[29]  E. Thom,et al.  Follow-up of Children Exposed In Utero to 17 &agr;-Hydroxyprogesterone Caproate Compared With Placebo , 2007, Obstetrics and gynecology.

[30]  U. Reddy,et al.  Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. , 2007, Obstetrics and gynecology.

[31]  R. Agarwal,et al.  Oral micronized progesterone for prevention of preterm birth , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[32]  H. Simhan,et al.  Can we communicate gravidity and parity better? , 2009, Obstetrics and gynecology.

[33]  E. Thom,et al.  The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. , 1996, The New England journal of medicine.

[34]  Sandy Oliver,et al.  Interventions for promoting smoking cessation during pregnancy. , 2009, The Cochrane database of systematic reviews.

[35]  P. Lumbiganon,et al.  Prophylactic antibiotic administration during second and third trimester in pregnancy for preventing infectious morbidity and mortality , 2002 .

[36]  P. Meis,et al.  A Randomized Trial of Nurse Intervention to Reduce Preterm and Low Birth Weight Births , 1998, Obstetrics and gynecology.

[37]  H. V. van Geijn,et al.  Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. , 2003, American journal of obstetrics and gynecology.

[38]  L. Poston,et al.  General obstetrics: A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study , 2006, BJOG : an international journal of obstetrics and gynaecology.

[39]  O. Shebl,et al.  Birth weight is lower for survivors of the vanishing twin syndrome: a case-control study. , 2008, Fertility and sterility.

[40]  V. Berghella,et al.  Cerclage for Short Cervix on Ultrasonography: Meta-Analysis of Trials Using Individual Patient-Level Data , 2005, Obstetrics and gynecology.

[41]  I. Chalmers,et al.  A randomized controlled trial of cervical cerclage in women at high risk of spontaneous preterm delivery , 1984 .

[42]  K. Nash,et al.  Are women who have had a preterm twin delivery at greater risk of preterm birth in a subsequent singleton pregnancy? , 2007, American journal of obstetrics and gynecology.

[43]  Progesterone and the risk of preterm birth among women with a short cervix. , 2007, The New England journal of medicine.

[44]  S. Kohl,et al.  Epidemiology of preterm delivery. , 1980, Clinical obstetrics and gynecology.

[45]  Michael F. Wangler,et al.  Racial disparity in the frequency of recurrence of preterm birth. , 2007, American journal of obstetrics and gynecology.

[46]  F. Smaill,et al.  Antibiotics for asymptomatic bacteriuria in pregnancy. , 2015, The Cochrane database of systematic reviews.

[47]  Sara Ellis Simonsen,et al.  Estimating Recurrence of Spontaneous Preterm Delivery , 2008, Obstetrics and gynecology.

[48]  G. Thurnau,et al.  The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1998, American journal of obstetrics and gynecology.

[49]  M. Merialdi,et al.  The Global Impact of Preterm Birth , 2010 .

[50]  J. Dodd,et al.  Prenatal administration of progesterone for preventing preterm birth. , 2006, The Cochrane database of systematic reviews.

[51]  C. Pennell,et al.  Treatment of Periodontal Disease During Pregnancy: A Randomized Controlled Trial , 2009, Obstetrics and gynecology.

[52]  M. Sammel,et al.  Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). , 2010, American journal of obstetrics and gynecology.

[53]  R. Newman,et al.  Prognostic significance of prior preterm twin delivery on subsequent singleton pregnancy. , 1996, American journal of obstetrics and gynecology.

[54]  M. Hannah,et al.  Interventions for treating bacterial vaginosis in pregnancy. , 2000, The Cochrane database of systematic reviews.

[55]  Steve N Caritis,et al.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. , 2003, The New England journal of medicine.

[56]  D. Richardson,et al.  Controlled trial of a preterm labor detection program: Efficacy and costs , 1989, Obstetrics and gynecology.

[57]  P. Meis 17 hydroxyprogesterone for the prevention of preterm delivery. , 2005, Obstetrics and gynecology.

[58]  B. Sibai,et al.  Randomized Clinical Trial of Metronidazole Plus Erythromycin to Prevent Spontaneous Preterm Delivery in Fetal Fibronectin–Positive Women , 2003, Obstetrics and gynecology.

[59]  K. Kagan,et al.  Preterm birth: the value of sonographic measurement of cervical length , 2006, BJOG : an international journal of obstetrics and gynaecology.

[60]  E. Hodnett,et al.  Support during pregnancy for women at increased risk. , 2000, The Cochrane database of systematic reviews.

[61]  Brett A. Collins,et al.  Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. , 2001, The New England journal of medicine.

[62]  V. Berghella,et al.  Prior Cerclage: To Repeat or Not to Repeat? That Is the Question , 2008, American journal of perinatology.

[63]  S. Cox,et al.  Society for Maternal-Fetal Medicine , 1999 .

[64]  J. Hauth,et al.  Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis , 1995, The New England journal of medicine.

[65]  I. Chalmers,et al.  Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists Multicentre Randomised Trial of Cervical Cerclage , 1993 .

[66]  K. Nicolaides,et al.  Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[67]  W. Callaghan,et al.  Estimated Effect of 17 Alpha-Hydroxyprogesterone Caproate on Preterm Birth in the United States , 2005, Obstetrics and gynecology.

[68]  P. Shah,et al.  Induced termination of pregnancy and low birthweight and preterm birth: a systematic review and meta‐analyses , 2009, BJOG : an international journal of obstetrics and gynaecology.

[69]  N. Nagelkerke,et al.  Antimicrobial prophylaxis in pregnancy: a randomized, placebo-controlled trial with cefetamet-pivoxil in pregnant women with a poor obstetric history. , 1997, American journal of obstetrics and gynecology.

[70]  J. Cutler,et al.  Trial of calcium to prevent preeclampsia. , 1997, The New England journal of medicine.

[71]  C. Hobel,et al.  The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women , 1994 .

[72]  M. Dombrowski,et al.  The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1999, American journal of obstetrics and gynecology.

[73]  Elizabeth A Thom,et al.  Frequency of uterine contractions and the risk of spontaneous preterm delivery. , 2002, The New England journal of medicine.

[74]  M. Kaminski,et al.  Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study , 2005 .

[75]  S. Daly,et al.  Expectant management compared with physical examination-indicated cerclage (EM-PEC) in selected women with a dilated cervix at 14(0/7)-25(6/7) weeks: results from the EM-PEC international cohort study. , 2007, American journal of obstetrics and gynecology.

[76]  S. Srinivas,et al.  Second-trimester loss and subsequent pregnancy outcomes: What is the real risk? , 2006, American journal of obstetrics and gynecology.

[77]  L. Doyle,et al.  Magnesium sulphate for preventing preterm birth in threatened preterm labour. , 2002, The Cochrane database of systematic reviews.

[78]  H. Bruinse,et al.  Prophylactic administration of clindamycin 2 % vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo‐controlled double‐blind trial , 1999, British journal of obstetrics and gynaecology.

[79]  J. Iams,et al.  Rates of recurrent preterm birth by obstetrical history and cervical length. , 2005, American journal of obstetrics and gynecology.

[80]  J. Hauth,et al.  Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. , 2006, American journal of obstetrics and gynecology.

[81]  V. Flenady,et al.  Oxytocin receptor antagonists for inhibiting preterm labour. , 2014, The Cochrane database of systematic reviews.

[82]  E. Waters,et al.  Interventions for promoting smoking cessation during pregnancy. , 2000, The Cochrane database of systematic reviews.

[83]  E. Mueller-Heubach,et al.  Preterm birth prevention: evaluation of a prospective controlled randomized trial. , 1989, American journal of obstetrics and gynecology.

[84]  Armstrong Ma,et al.  Monitoring women at risk for preterm labor , 1998 .

[85]  S. Quenby,et al.  Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies. , 2008, The Cochrane database of systematic reviews.

[86]  C. Daskalakis,et al.  Gestational Age at Cervical Length Measurement and Incidence of Preterm Birth , 2007, Obstetrics and gynecology.

[87]  Effects of Periodontal Therapy on Rate of Preterm Delivery: A Randomized Controlled Trial , 2009, Obstetrics and gynecology.

[88]  Ichael,et al.  METRONIDAZOLE TO PREVENT PRETERM DELIVERY IN PREGNANT WOMEN WITH ASYMPTOMATIC BACTERIAL VAGINOSIS , 2000 .

[89]  R. Renaud,et al.  Multicentred controlled trial of cervical cerclage in women at moderate risk of preterm delivery , 1984, British journal of obstetrics and gynaecology.

[90]  C. Hobel,et al.  The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women. , 1994, American journal of obstetrics and gynecology.

[91]  M. Gissler,et al.  Preterm Delivery After Surgical Treatment for Cervical Intraepithelial Neoplasia , 2007, Obstetrics and gynecology.

[92]  P. Middleton,et al.  Oral betamimetics for maintenance therapy after threatened preterm labour. , 2012, The Cochrane database of systematic reviews.

[93]  Caroline A Crowther,et al.  Vitamins C and E and the risks of preeclampsia and perinatal complications. , 2006, New England Journal of Medicine.

[94]  E. Salamalekis,et al.  The value of transvaginal ultrasonography in diagnosis and management of cervical incompetence. , 2001, Clinical and experimental obstetrics & gynecology.

[95]  L. Akinbami,et al.  Prenatal Smoking Cessation and the Risk of Delivering Preterm and Small-for-Gestational-Age Newborns , 2009, Obstetrics and gynecology.

[96]  V. Berghella,et al.  Novel developments on cervical length screening and progesterone for preventing preterm birth , 2009, BJOG : an international journal of obstetrics and gynaecology.

[97]  S. F. Olsen,et al.  Randomised clinical trials of fish oil supplementation in high risk pregnancies , 2000, BJOG : an international journal of obstetrics and gynaecology.

[98]  D. Wing,et al.  Does midtrimester cervical length ≥25 mm predict preterm birth in high-risk women? , 2009, American journal of obstetrics and gynecology.

[99]  C. Koebnick,et al.  The association between stillbirth in the first pregnancy and subsequent adverse perinatal outcomes. , 2009, American journal of obstetrics and gynecology.

[100]  M. Klebanoff,et al.  Omega-3 Fatty Acid Supplementation to Prevent Recurrent Preterm Birth: A Randomized Controlled Trial , 2010, Obstetrics and gynecology.

[101]  G. Dekker,et al.  Calcium channel blockers for inhibiting preterm labour. , 2003, The Cochrane database of systematic reviews.

[102]  L. Henriet,et al.  Impact of induced abortions on subsequent pregnancy outcome: the 1995 French national perinatal survey , 2001, BJOG : an international journal of obstetrics and gynaecology.

[103]  L. Poston,et al.  A randomized controlled trial of cervical scanning vs history to determine cerclage in women at high risk of preterm birth (CIRCLE trial). , 2009, American journal of obstetrics and gynecology.

[104]  Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. , 2008, American journal of obstetrics and gynecology.

[105]  E. Amon,et al.  Recurrence risk for preterm delivery. , 2007, American journal of obstetrics and gynecology.

[106]  E. Hodnett,et al.  Support during pregnancy for women at increased risk of low birthweight babies. , 2003, The Cochrane database of systematic reviews.

[107]  J. King,et al.  Cyclo-oxygenase (COX) inhibitors for treating preterm labour. , 2005, The Cochrane database of systematic reviews.

[108]  R. Wapner,et al.  Patients with a prior failed transvaginal cerclage: a comparison of obstetric outcomes with either transabdominal or transvaginal cerclage. , 2000, American journal of obstetrics and gynecology.

[109]  P. McDonald,et al.  Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial , 1997, British journal of obstetrics and gynaecology.

[110]  J. Weeks,et al.  Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double‐blind, placebo‐controlled trial , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[111]  R. Carr-Hill,et al.  The repetition of spontaneous preterm labour , 1985, British journal of obstetrics and gynaecology.